ClinPharm Consulting has made two major staffing changes: chief scientific officer M. Alexander Shaw, Ph.D., has been promoted to chief operating officer, and Bill Wargin, Ph.D., has been appointed chief scientific officer.

Dr. Shaw transitions to a wider role within the company to roll out and formalize new services aimed at meeting diverse customer and project needs. Dr. Wargin will drive scientific and PK strategy for clients’ drug development programs, including the representation of clients during interactions with the FDA and support for ClinPharm’s new services, which will be announced soon.

“Bill has been working with us since 2008 focusing on pharmacokinetic strategic planning for our clients’ preclinical and clinical programs, and his 25 years of experience in the pharmaceutical industry brings a huge knowledge base of drug development experience to the table,” said ClinPharm president and chief executive officer, Geoffrey Banks, Ph.D.